Beppu Toru, Doi Koichi, Matsuda Teishi, Isiko Takatoshi, Yamanaka Tsuyoshi, Ogawa Michio
Dept. of Surgery II, Kumamoto University Medical School.
Gan To Kagaku Ryoho. 2002 Nov;29(12):2247-51.
We have developed a new therapeutic modality: laparoscopic devascularization (LDEV) for hepatocellular carcinoma (HCC). Thirteen patients with HCC were treated with LDEV from March 1998 to March 2002. All LDEV procedures were performed under laparoscopic surgery using laparoscopic coagulating shears (LCS), endo-clip and endo-GIA. To prevent recanalization of extra-hepatic feeding arteries, we always add local ablation therapy (LAT) intraoperatively. The results are as follows. 1. The right gastroepiploic artery in 11 patients, right gastric artery in 1 and right inferior phrenic artery in 2 were devascularized. 2. The amount of intraoperative bleeding ranged 5-150 g and the operating time for devasculalization ranged 5-50 min, with an average of 30 min. 3. LAT was also performed in all cases. 4. No complications occurred. 5. A recurrent feeding artery developed in only one case (8%). 6. Nine patients are living (6-52, average 27 months) and 4 have died (5-28, average 16 months).
用于肝细胞癌(HCC)的腹腔镜去血管化术(LDEV)。1998年3月至2002年3月期间,13例肝细胞癌患者接受了LDEV治疗。所有LDEV手术均在腹腔镜手术下进行,使用腹腔镜凝固剪(LCS)、内镜夹和内镜切割吻合器。为防止肝外供血动脉再通,我们术中总是加用局部消融治疗(LAT)。结果如下:1. 11例患者的胃网膜右动脉、1例患者的胃右动脉和2例患者的膈下右动脉被去血管化。2. 术中出血量为5 - 150克,去血管化操作时间为5 - 50分钟,平均30分钟。3. 所有病例均进行了LAT。4. 未发生并发症。5. 仅1例(8%)出现复发性供血动脉。6. 9例患者存活(6 - 52个月,平均27个月),4例死亡(5 - 28个月,平均16个月)。